134 related articles for article (PubMed ID: 35379174)
1. Identification and functional validation of HLA-C as a potential gene involved in colorectal cancer in the Korean population.
Lim EB; Oh HS; Kim KC; Kim MH; Kim YJ; Kim BJ; Nho CW; Cho YS
BMC Genomics; 2022 Apr; 23(1):261. PubMed ID: 35379174
[TBL] [Abstract][Full Text] [Related]
2. RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer.
Li XN; Wang ZJ; Ye CX; Zhao BC; Li ZL; Yang Y
J Exp Clin Cancer Res; 2018 Dec; 37(1):325. PubMed ID: 30591054
[TBL] [Abstract][Full Text] [Related]
3. The Relationship Between Killer Cell Immunoglobulin-Like Receptors and HLA-C Polymorphisms in Colorectal Cancer in a Saudi Population.
Al Omar SY; Mansour L; Dar JA; Alwasel S; Alkhuriji A; Arafah M; Al Obeed O; Christmas S
Genet Test Mol Biomarkers; 2015 Nov; 19(11):617-22. PubMed ID: 26383988
[TBL] [Abstract][Full Text] [Related]
4. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.
Bianchini M; Levy E; Zucchini C; Pinski V; Macagno C; De Sanctis P; Valvassori L; Carinci P; Mordoh J
Int J Oncol; 2006 Jul; 29(1):83-94. PubMed ID: 16773188
[TBL] [Abstract][Full Text] [Related]
6. The identification of a common different gene expression signature in patients with colorectal cancer.
Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
[TBL] [Abstract][Full Text] [Related]
7. Systematic Functional Interrogation of Genes in GWAS Loci Identified ATF1 as a Key Driver in Colorectal Cancer Modulated by a Promoter-Enhancer Interaction.
Tian J; Chang J; Gong J; Lou J; Fu M; Li J; Ke J; Zhu Y; Gong Y; Yang Y; Zou D; Peng X; Yang N; Mei S; Wang X; Zhong R; Cai K; Miao X
Am J Hum Genet; 2019 Jul; 105(1):29-47. PubMed ID: 31204011
[TBL] [Abstract][Full Text] [Related]
8. Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage.
Canossi A; Aureli A; Del Beato T; Rossi P; Franceschilli L; De Sanctis F; Sileri P; di Lorenzo N; Buonomo O; Lauro D; Venditti A; Sconocchia G
J Transl Med; 2016 Aug; 14(1):239. PubMed ID: 27519478
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
[TBL] [Abstract][Full Text] [Related]
10. Identification of key genes involved in JAK/STAT pathway in colorectal cancer.
Yue Y; Zhang Q; Wu S; Wang S; Cui C; Yu M; Sun Z
Mol Immunol; 2020 Dec; 128():287-297. PubMed ID: 33248399
[TBL] [Abstract][Full Text] [Related]
11. miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression.
Ye YP; Wu P; Gu CC; Deng DL; Jiao HL; Li TT; Wang SY; Wang YX; Xiao ZY; Wei WT; Chen YR; Qiu JF; Yang RW; Lin J; Liang L; Liao WT; Ding YQ
Oncotarget; 2016 Sep; 7(38):61312-61324. PubMed ID: 27494869
[TBL] [Abstract][Full Text] [Related]
12. HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.
Sconocchia G; Eppenberger-Castori S; Zlobec I; Karamitopoulou E; Arriga R; Coppola A; Caratelli S; Spagnoli GC; Lauro D; Lugli A; Han J; Iezzi G; Ferrone C; Ferlosio A; Tornillo L; Droeser R; Rossi P; Attanasio A; Ferrone S; Terracciano L
Neoplasia; 2014 Jan; 16(1):31-42. PubMed ID: 24563618
[TBL] [Abstract][Full Text] [Related]
13. HLA-Cw polypmorphism and killer cell immunoglobulin-like receptor (KIR) gene analysis in Korean colorectal cancer patients.
Kim HJ; Choi HB; Jang JP; Baek IC; Choi EJ; Park M; Kim TG; Oh ST
Int J Surg; 2014; 12(8):815-20. PubMed ID: 24998207
[TBL] [Abstract][Full Text] [Related]
14. HLA Class I Analysis Provides Insight Into the Genetic and Epigenetic Background of Immune Evasion in Colorectal Cancer With High Microsatellite Instability.
Kawazu M; Ueno T; Saeki K; Sax N; Togashi Y; Kanaseki T; Chida K; Kishigami F; Sato K; Kojima S; Otsuka M; Kawazoe A; Nishinakamura H; Yuka M; Yamamoto Y; Yamashita K; Inoue S; Tanegashima T; Matsubara D; Tane K; Tanaka Y; Iinuma H; Hashiguchi Y; Hazama S; Khor SS; Tokunaga K; Tsuboi M; Niki T; Eto M; Shitara K; Torigoe T; Ishihara S; Aburatani H; Haeno H; Nishikawa H; Mano H
Gastroenterology; 2022 Mar; 162(3):799-812. PubMed ID: 34687740
[TBL] [Abstract][Full Text] [Related]
15. Identification of Key Candidate Genes and Pathways in Colorectal Cancer by Integrated Bioinformatical Analysis.
Guo Y; Bao Y; Ma M; Yang W
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28350360
[TBL] [Abstract][Full Text] [Related]
16. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
Liang B; Li C; Zhao J
Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
[TBL] [Abstract][Full Text] [Related]
17. Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer.
Bellido F; Sowada N; Mur P; Lázaro C; Pons T; Valdés-Mas R; Pineda M; Aiza G; Iglesias S; Soto JL; Urioste M; Caldés T; Balbín M; Blay P; Rueda D; Durán M; Valencia A; Moreno V; Brunet J; Blanco I; Navarro M; Calin GA; Borck G; Puente XS; Capellá G; Valle L
Gastroenterology; 2018 Jan; 154(1):181-194.e20. PubMed ID: 28912018
[TBL] [Abstract][Full Text] [Related]
18. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development.
Piao MY; Cao HL; He NN; Xu MQ; Dong WX; Wang WQ; Wang BM; Zhou B
Scand J Gastroenterol; 2016; 51(5):572-82. PubMed ID: 26691157
[TBL] [Abstract][Full Text] [Related]
19. Identification of genes involved in the four stages of colorectal cancer: Gene expression profiling.
Shi G; Wang Y; Zhang C; Zhao Z; Sun X; Zhang S; Fan J; Zhou C; Zhang J; Zhang H; Liu J
Mol Cell Probes; 2018 Feb; 37():39-47. PubMed ID: 29179987
[TBL] [Abstract][Full Text] [Related]
20. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]